Browse > Article
http://dx.doi.org/10.3904/kjm.2012.82.2.185

Predictors of Contrast-Induced Nephropathy in Acute Coronary Syndrome Patients with Renal Dysfunction  

Park, Soo-Hwan (The Heart Center of Chonnam National University Hospital)
Jeong, Myung-Ho (The Heart Center of Chonnam National University Hospital)
Rhee, Jung-Ae (Department of Preventive Medicine, Chonnam National University Medical School)
Choi, Jin-Su (Department of Preventive Medicine, Chonnam National University Medical School)
Hwang, Seung-Hwan (The Heart Center of Chonnam National University Hospital)
Ko, Jum-Suk (The Heart Center of Chonnam National University Hospital)
Lee, Min-Goo (The Heart Center of Chonnam National University Hospital)
Sim, Doo-Sun (The Heart Center of Chonnam National University Hospital)
Park, Keun-Ho (The Heart Center of Chonnam National University Hospital)
Yoon, Nam-Sik (The Heart Center of Chonnam National University Hospital)
Yoon, Hyun-Ju (The Heart Center of Chonnam National University Hospital)
Kim, Kye-Hun (The Heart Center of Chonnam National University Hospital)
Hong, Young-Joon (The Heart Center of Chonnam National University Hospital)
Kim, Ju-Han (The Heart Center of Chonnam National University Hospital)
Ahn, Young-Keun (The Heart Center of Chonnam National University Hospital)
Cho, Jeong-Gwan (The Heart Center of Chonnam National University Hospital)
Park, Jong-Chun (The Heart Center of Chonnam National University Hospital)
Kang, Jung-Chaee (The Heart Center of Chonnam National University Hospital)
Publication Information
The Korean Journal of Medicine / v.82, no.2, 2012 , pp. 185-193 More about this Journal
Abstract
Background/Aims: Contrast-induced nephropathy (CIN) is an important complication of diagnostic coronary angiography (CAG) and percutaneous coronary intervention (PCI). We investigated the incidence and predictors of the development of CIN in acute coronary syndrome (ACS) patients with renal dysfunction undergoing PCI. Methods: From January 2005 to June 2010, we evaluated the clinical, laboratory, and angiographic data of 406 patients with ACS who had a serum creatinine ${\geq}$ 1.3 mg/dL and underwent CAG or PCI. The patients were divided into two groups according to the development of CIN (CIN, n = 92; no CIN, n = 314). Results: Of the 406 patients, 92 (22.7%) developed CIN. The development of CIN was associated with a lower baseline body mass index (p = 0.001), decreased left ventricular ejection fraction (LVEF) (p < 0.001), decreased creatinine clearance (CrCl) (p < 0.001), lower albumin (p < 0.001), lower hemoglobin (p = 0.003), higher N-terminal pro B type natriuretic peptide (p = 0.001), and greater contrast medium volume (CMV) (p = 0.021). On multiple logistic regression analysis, LVEF < 40% (OR, 4.080; 95% CI, 2.087-7.977; p < 0.001), albumin < 3.5 g/dL (OR, 2.042; 95% CI, 1.211-3.440; p = 0.007), and CMV/CrCl ${\geq}$ 3.5 (OR, 1.964; 95% CI, 1.243-3.101; p = 0.004) were independent predictors of CIN. The cut-off value for CMV/CrCl was 3.5, and that for albumin was 3.55 g/dL. Conclusions: CIN occurred in 22.7% of the patients with ACS and renal dysfunction who underwent CAG or PCI. Independent predictors of CIN were decreased LVEF, decreased albumin, and increased CMV/CrCl ratio.
Keywords
Contrast-induced nephropathy; Acute coronary syndrome; Renal dysfunction;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Anderson RJ, Linas SL, Berns AS, et al. Nonoliguric acute renal failure. N Engl J Med 1997;296:1134-1138.
2 Cho JY, Jeong MH, Park SH, et al. Effect of contrastinduced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure. J Cardiol 2010;56:300-306.   DOI
3 Pannu N, Wiebe N, Tonelli M; Alberta Kidney Disease Network. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006;295:2765-2779.   DOI
4 Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994;45:259-265.   DOI
5 Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005;68:14-22.   DOI
6 McCullough PA, Soman SS. Contrast-induced nephropathy. Crit Care Clin 2005;21:261-280.   DOI
7 Choi W, Lim HM, Won HJ, et al. Contrast-induced nephropathy in patients undergoing percutaneous coronary angiography and its clinical characteristics. Korean J Nephrol 2008;27:55-61.
8 Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983;74:243-248.   DOI
9 Laskey WK, Jenkins C, Selzer F, et al. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 2007;50:584-590.   DOI
10 Szummer K, Lundman P, Jacobson SH, et al. Cockcroft- Gault is better than the Modification of Diet in Renal Disease study formula at predicting outcome after a myocardial infarction: data from the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART). Am Heart J 2010;159:979-986.   DOI
11 McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008;51:1419-1428. Erratum in: J Am Coll Cardiol 2008;51:2197.   DOI
12 Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-684.   DOI
13 Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection: Multivessel Angioplasty Prognosis Study Group. Circulation 1990;82:1193-1202.   DOI
14 Kim YS, Song SW, Ku YM, et al. Clinical characteristics and risk factors of contrast dye nephrotoxicity in patients performing arteriography. Korean J Nephrol 2004;23:248-255.
15 Cho YS, Chung TN, Sohn DK, Kim SH. Contrast nephrotoxicity associated with emergency CT scans. J Korean Soc Emerg Med 2003;14:157-161.
16 Davidson CJ, Hlatky M, Morris KG, et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization: a prospective trial. Ann Intern Med 1989;110:119-124.   DOI
17 Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989;86(6 Pt 1):649-652.   DOI
18 Shaper AG, Wannamethee SG, Whincup PH. Serum albumin and risk of stroke, coronary heart disease, and mortality: the role of cigarette smoking. J Clin Epidemiol 2004;57:195-202.   DOI
19 Vuong TD, Braam B, Willekes-Koolschijn N, Boer P, Koomans HA, Joles JA. Hypoalbuminaemia enhances the renal vasoconstrictor effect of lysophosphatidylcholine. Nephrol Dial Transplant 2003;18:1485-1492.   DOI
20 Nikolsky E, Mehran R, Lasic Z, et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kindey Int 2005;67:706-713.   DOI